Leadless Pacemaker Successfully Implanted in a Patient Post-Tricuspid Valve Replacement Following Cardiac Tumor Resection: A Case Study and Review of Existing Literature

By
Qi Zou
Peng Chang
Cheng Jiang
Pengyang Lin
Shougang Sun
October 28, 2025
0 min

Bmc Cardiovascular Disorders

Overview

Expand on the specific improvements in heart rhythm stability and quality of life.

Background

Tricuspid valve lesions can lead to significant cardiac complications, often requiring surgical intervention such as tricuspid valve replacement. The risk of cardiac conduction dysfunction post-surgery necessitates careful management, including potential pacemaker implantation. Leadless pacemakers offer a promising alternative for patients at risk of complications from traditional pacemaker leads.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

The patient developed third-degree AV block following tricuspid valve replacement due to prior cardiac tumor resection.
Leadless pacemaker (Micra) implantation was performed after conventional pacing options were deemed too risky.
Post-implantation, the patient exhibited stable ventricular pacing and improved quality of life.
Follow-up assessments showed stable device parameters and normal left ventricular function.
This case may represent one of the earliest instances of leadless pacemaker use in this specific clinical scenario.

Clinical Implications

The successful use of a leadless pacemaker in this case underscores its potential as a safe option for patients with advanced atrioventricular block following tricuspid valve replacement. Clinicians should consider leadless pacing as a viable alternative in similar high-risk patients to mitigate complications associated with traditional pacing methods.

Conclusion

This case study demonstrates the effective application of a leadless pacemaker in managing advanced AV block post-tricuspid valve replacement, highlighting its role in improving patient outcomes in complex cardiac scenarios.